{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T20:30:10Z","timestamp":1775507410706,"version":"3.50.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s11908-013-0321-9","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T01:33:16Z","timestamp":1359509596000},"page":"148-157","source":"Crossref","is-referenced-by-count":17,"title":["Could Vitamin D Have a Potential Anti-Inflammatory and Anti-Infective Role in Bronchiectasis?"],"prefix":"10.1007","volume":"15","author":[{"given":"Jim","family":"Bartley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron C.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Carlos A.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"key":"321_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2265.2011.04261.x","volume":"76","author":"M Hewison","year":"2012","unstructured":"\u2022\u2022 Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf). 2012;76:315\u201325. An excellent recent review of the role of vitamin D in human immunity.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"321_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/thx.2009.128793","volume":"65","author":"L Chishimba","year":"2010","unstructured":"Chishimba L, Thickett DR, Stockley RA, et al. The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax. 2010;65:456\u201362.","journal-title":"Thorax"},{"key":"321_CR3","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Chalmers J, McHugh B, Docherty C, et al. Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax 2013;68:39\u201347. Recent case series documenting the association of low 25(OH)D levels with bronchiectasis and bronchiectasis severity.","DOI":"10.1136\/thoraxjnl-2012-202125"},{"key":"321_CR4","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1542\/peds.2011-3029","volume":"130","author":"CA Camargo Jr","year":"2012","unstructured":"\u2022 Camargo Jr CA, Ganmaa D, Frazier A, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012;130:e561\u20137. A well-designed RCT showing a halving in incidence of upper respiratory tract infection in vitamin D deficient children given daily vitamin D supplementation.","journal-title":"Pediatrics"},{"key":"321_CR5","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3945\/ajcn.2009.29094","volume":"91","author":"M Urashima","year":"2010","unstructured":"Urashima M, Segawa T, Okazaki M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91:1255\u201360.","journal-title":"Am J Clin Nutr"},{"key":"321_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1365-3156.2010.02578.x","volume":"15","author":"S Manaseki-Holland","year":"2010","unstructured":"Manaseki-Holland S, Qader G, Isaq Masher M, et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health. 2010;15:1148\u201355.","journal-title":"Trop Med Int Health"},{"key":"321_CR7","doi-asserted-by":"publisher","first-page":"15449","DOI":"10.1073\/pnas.1200072109","volume":"109","author":"A Coussens","year":"2012","unstructured":"\u2022\u2022 Coussens A, Wilkinson R, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA. 2012;109:15449\u201354. An important clinical study documenting the anti-inflammatory actions of vitamin D in a clinical situation.","journal-title":"Proc Natl Acad Sci USA"},{"key":"321_CR8","volume-title":"Dietary reference intakes for calcium and vitamin D","author":"Institute of Medicine","year":"2010","unstructured":"Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press; 2010."},{"key":"321_CR9","first-page":"CD002166","volume":"3","author":"JM Bradley","year":"2002","unstructured":"Bradley JM, Moran F, Greenstone M. Physical training for bronchiectasis. Cochrane Database Syst Rev. 2002;3:CD002166.","journal-title":"Cochrane Database Syst Rev"},{"key":"321_CR10","first-page":"CD000996","volume":"1","author":"N Kapur","year":"2009","unstructured":"Kapur N, Bell S, Kolbe J, et al. Inhaled steroids for bronchiectasis. Cochrane Database Syst Rev. 2009;1:CD000996.","journal-title":"Cochrane Database Syst Rev"},{"key":"321_CR11","first-page":"CD002162","volume":"4","author":"T Lasserson","year":"2001","unstructured":"Lasserson T, Holt K, Greenstone M. Oral steroids for bronchiectasis (stable and acute exacerbations). Cochrane Database Syst Rev. 2001;4:CD002162.","journal-title":"Cochrane Database Syst Rev"},{"key":"321_CR12","first-page":"CD007525","volume":"4","author":"SJ Pizzutto","year":"2010","unstructured":"Pizzutto SJ, Upham JW, Yerkovich ST, et al. Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis. Cochrane Database Syst Rev. 2010;4:CD007525.","journal-title":"Cochrane Database Syst Rev"},{"key":"321_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","volume":"380","author":"C Wong","year":"2012","unstructured":"\u2022 Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380:660\u20137. Azithromycin appears an important antibiotic in bronchiectasis management.","journal-title":"Lancet"},{"key":"321_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ejcn.2010.194","volume":"65","author":"T Pincikova","year":"2011","unstructured":"Pincikova T, Nilsson K, Moen IE, et al. Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study. Eur J Clin Nutr. 2011;65:102\u20139.","journal-title":"Eur J Clin Nutr"},{"key":"321_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/COPD.S6133","volume":"4","author":"P King","year":"2009","unstructured":"King P. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis. 2009;4:411\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"321_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D, deficiency. N Eng J Med. 2007;357:266\u201381.","journal-title":"N Eng J Med"},{"key":"321_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2174\/156802612799436623","volume":"12","author":"C Carlberg","year":"2012","unstructured":"Carlberg C, Molnar F. Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem. 2012;12:528\u201347.","journal-title":"Curr Top Med Chem"},{"key":"321_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389\u201395.","journal-title":"Nature"},{"key":"321_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/0036554021000028089","volume":"123","author":"ST Kim","year":"2003","unstructured":"Kim ST, Cha HE, Kim DY, et al. Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Otolaryngol. 2003;123:81\u20135.","journal-title":"Acta Otolaryngol"},{"key":"321_CR20","doi-asserted-by":"publisher","first-page":"9541","DOI":"10.1073\/pnas.95.16.9541","volume":"95","author":"R Bals","year":"1998","unstructured":"Bals R, Wang X, Zasloff M, et al. The peptide antibiotic LL-37\/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A. 1998;95:9541\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"321_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0022-1759(99)00152-0","volume":"232","author":"GH Gudmundsson","year":"1999","unstructured":"Gudmundsson GH, Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J Immunol Methods. 1999;232:45\u201354.","journal-title":"J Immunol Methods"},{"key":"321_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3:238\u201350.","journal-title":"Nat Rev Microbiol"},{"key":"321_CR23","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/IAI.66.11.5314-5321.1998","volume":"66","author":"KA Rockett","year":"1998","unstructured":"Rockett KA, Brookes R, Udalova I, et al. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun. 1998;66:5314\u201321.","journal-title":"Infect Immun"},{"key":"321_CR24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.124.5.677","volume":"124","author":"M Desjardins","year":"1994","unstructured":"Desjardins M, Huber LA, Parton RG, et al. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J Cell Biol. 1994;124:677\u201388.","journal-title":"J Cell Biol"},{"key":"321_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0962-8924(00)88963-1","volume":"5","author":"DG Russell","year":"1995","unstructured":"Russell DG. Mycobacterium and Leishmania: stowaways in the endosomal network. Trends Cell Biol. 1995;5:125\u20138.","journal-title":"Trends Cell Biol"},{"key":"321_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0952-7915(00)00179-5","volume":"13","author":"J Pieters","year":"2001","unstructured":"Pieters J. Evasion of host cell defense mechanisms by pathogenic bacteria. Curr Opin Immunol. 2001;13:37\u201344.","journal-title":"Curr Opin Immunol"},{"key":"321_CR27","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1242\/jcs.01072","volume":"15","author":"Z Hmama","year":"2004","unstructured":"Hmama Z, Sendide K, Talal A, et al. Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1alpha,25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway. J Cell Sci. 2004;15:2131\u201340.","journal-title":"J Cell Sci"},{"key":"321_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2567.2008.03024.x","volume":"127","author":"A Coussens","year":"2009","unstructured":"Coussens A, Timms PM, Boucher BJ, et al. 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology. 2009;127:539\u201348.","journal-title":"Immunology"},{"key":"321_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.humimm.2009.01.016","volume":"70","author":"L Adorini","year":"2009","unstructured":"Adorini L, Penna G. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol. 2009;70:345\u201352.","journal-title":"Hum Immunol"},{"key":"321_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature06175","volume":"449","author":"RM Steinman","year":"2007","unstructured":"Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419\u201326.","journal-title":"Nature"},{"key":"321_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jdermsci.2007.03.002","volume":"46","author":"K Mahnke","year":"2007","unstructured":"Mahnke K, Johnson TS, Ring S, et al. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J Dermatol Sci. 2007;46:159\u201367.","journal-title":"J Dermatol Sci"},{"key":"321_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJM200008033430506","volume":"343","author":"R Medzhitov","year":"2000","unstructured":"Medzhitov R, Janeway Jr C. Innate immunity. N Engl J Med. 2000;343:338\u201344.","journal-title":"N Engl J Med"},{"key":"321_CR33","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/90601","volume":"2","author":"DH Margulies","year":"2001","unstructured":"Margulies DH. TCR avidity: it\u2019s not how strong you make it, it\u2019s how you make it strong. Nat Immunol. 2001;2:669\u201370.","journal-title":"Nat Immunol"},{"key":"321_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/90650","volume":"2","author":"MK Slifka","year":"2001","unstructured":"Slifka MK, Whitton JL. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat Immunol. 2001;2:711\u20137.","journal-title":"Nat Immunol"},{"issue":"6 Suppl","key":"321_CR35","doi-asserted-by":"crossref","first-page":"1704S","DOI":"10.1093\/jn\/125.suppl_6.1704S","volume":"125","author":"JM Lemire","year":"1995","unstructured":"Lemire JM, Archer DC, Beck L, et al. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr. 1995;125(6 Suppl):1704S\u20138.","journal-title":"J Nutr"},{"key":"321_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11882-010-0161-8","volume":"11","author":"ES Chambers","year":"2011","unstructured":"Chambers ES, Hawrylowicz CM. The impact of vitamin D on regulatory T cells. Curr Allergy Asthma Rep. 2011;11:29\u201336.","journal-title":"Curr Allergy Asthma Rep"},{"key":"321_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DAA Vignali","year":"2008","unstructured":"Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Review Immunol. 2008;8:523\u201332.","journal-title":"Nat Review Immunol"},{"key":"321_CR38","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.4049\/jimmunol.0803217","volume":"183","author":"LE Jeffery","year":"2009","unstructured":"Jeffery LE, Burke F, Mura M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183:5458\u201367.","journal-title":"J Immunol"},{"key":"321_CR39","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","volume":"179","author":"S Chen","year":"2007","unstructured":"Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179:1634\u201347.","journal-title":"J Immunol"},{"key":"321_CR40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jsbmb.2010.02.029","volume":"120","author":"S Dimeloe","year":"2010","unstructured":"Dimeloe S, Nanzer A, Ryanna K, et al. Regulatory T cells, inflammation and the allergic response - The role of glucocorticoids and Vitamin D. J Steroid Biochem Mol Biol. 2010;120:86\u201395.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"321_CR41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1067\/mai.2000.110101","volume":"106","author":"O Jirapongsananuruk","year":"2000","unstructured":"Jirapongsananuruk O, Melamed I, Leung DY. Additive immunosuppressive effects of 1,25(OH)2D3 and corticosteroids on Th1, but not Th2, responses. J Allergy Clin Immunol. 2000;106:981\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"321_CR42","first-page":"12","volume":"52","author":"J Pichler","year":"2002","unstructured":"Pichler J, Gerstmayr M, Szepfalusi Z, et al. 1 alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res. 2002;52:12\u20138.","journal-title":"Pediatr Res"},{"key":"321_CR43","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jaci.2011.07.015","volume":"128","author":"J Rothers","year":"2011","unstructured":"\u2022 Rothers J, Wright A, Halonen M, et al. Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona. J Allergy Clin Immunol. 2011;128:1093\u20139. This article has shown that both high and low 25-hydroxyvitamin D levels are associated with aeroallergen sensitization.","journal-title":"J Allergy Clin Immunol"},{"key":"321_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1128\/CMR.15.2.155-166.2002","volume":"15","author":"WM Dunne Jr","year":"2002","unstructured":"Dunne Jr WM. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev. 2002;15:155\u201366.","journal-title":"Clin Microbiol Rev"},{"key":"321_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/3-540-29916-5_10","volume":"306","author":"M Otto","year":"2006","unstructured":"Otto M. Bacterial evasion of antimicrobial peptides by biofilm formation. Curr Top Microbiol Immunol. 2006;306:251\u20138.","journal-title":"Curr Top Microbiol Immunol"},{"key":"321_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1365-2958.2002.03146.x","volume":"46","author":"A Schmidtchen","year":"2002","unstructured":"Schmidtchen A, Frick I-M, Andersson E, et al. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol. 2002;46:157\u201368.","journal-title":"Mol Microbiol"},{"key":"321_CR47","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.bbamem.2006.05.017","volume":"1758","author":"Y Rosenfeld","year":"2006","unstructured":"Rosenfeld Y, Shai Y. Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta. 2006;1758:1513\u201322.","journal-title":"Biochim Biophys Acta"},{"key":"321_CR48","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1128\/IAI.00318-08","volume":"76","author":"J Overhage","year":"2008","unstructured":"Overhage J, Campisano A, Bains M, et al. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Imm. 2008;76:4176\u201382.","journal-title":"Infect Imm"},{"key":"321_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2500\/ajra.2009.23.3261","volume":"23","author":"SK Chennupati","year":"2009","unstructured":"Chennupati SK, Chiu AG, Tamashiro E, et al. Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis. Am J Rhinol Allergy. 2009;23:46\u201351.","journal-title":"Am J Rhinol Allergy"},{"key":"321_CR50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/00365541003602049","volume":"42","author":"EM Matheson","year":"2010","unstructured":"Matheson EM, Mainous 3rd AG, Hueston WJ, et al. Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage. Scand J Infect Dis. 2010;42:455\u201360.","journal-title":"Scand J Infect Dis"},{"key":"321_CR51","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10096-011-1331-x","volume":"31","author":"K Olsen","year":"2012","unstructured":"Olsen K, Falch BM, Danielsen K, et al. Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels. Eur J Clin Microbiol Infect Dis. 2012;31:465\u201373.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"321_CR52","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/thx.2003.016105","volume":"59","author":"KM Eastham","year":"2004","unstructured":"Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax. 2004;59:522\u20135.","journal-title":"Thorax"},{"key":"321_CR53","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","volume":"162","author":"MC Pasteur","year":"2000","unstructured":"Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Resp Crit Care Med. 2000;162:1277\u201384.","journal-title":"Am J Resp Crit Care Med"},{"key":"321_CR54","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1440-1843.1996.tb00037.x","volume":"1","author":"J Kolbe","year":"1996","unstructured":"Kolbe J, Wells A. Bronchiectasis: a neglected cause of respiratory morbidity and mortality. Respirology. 1996;1:221\u20135.","journal-title":"Respirology"},{"key":"321_CR55","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.rmed.2010.02.022","volume":"104","author":"HJ Roberts","year":"2010","unstructured":"Roberts HJ, Hubbard R. Trends in bronchiectasis mortality in England and Wales. Respir Med. 2010;104:981\u20135.","journal-title":"Respir Med"},{"key":"321_CR56","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1378\/chest.10-0099","volume":"138","author":"AE Seitz","year":"2010","unstructured":"Seitz AE, Olivier KN, Steiner CA, et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993\u20132006. Chest. 2010;138:944\u20139.","journal-title":"Chest"},{"key":"321_CR57","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/adc.36.190.587","volume":"36","author":"CE Field","year":"1961","unstructured":"Field CE. Bronchiectasis. A long-term follow-up of medical and surgical cases from childhood. Arch Dis Child. 1961;36:587\u2013603.","journal-title":"Arch Dis Child"},{"key":"321_CR58","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/adc.2004.066472","volume":"90","author":"J Twiss","year":"2005","unstructured":"Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis \u201ctoo high\u201d for a developed country. Arch Dis Child. 2005;90:737\u201340.","journal-title":"Arch Dis Child"},{"key":"321_CR59","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ppul.21036","volume":"44","author":"K Haidopoulou","year":"2009","unstructured":"Haidopoulou K, Calder A, Jones A, et al. Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function. Pediatr Pulmonol. 2009;44:669\u201375.","journal-title":"Pediatr Pulmonol"},{"key":"321_CR60","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/thx.2003.011577","volume":"59","author":"KM Eastham","year":"2004","unstructured":"Eastham KM, Fall AJ, Mitchell L, et al. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax. 2004;59:324\u20137.","journal-title":"Thorax"},{"key":"321_CR61","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1479972308091823","volume":"5","author":"J Courtney","year":"2008","unstructured":"Courtney J, Kelly M, Watt A, et al. Quality of life and inflammation in exacerbations of bronchiectasis. Chron Respir Dis. 2008;5:161\u20138.","journal-title":"Chron Respir Dis"},{"key":"321_CR62","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1378\/chest.125.5.1815","volume":"125","author":"M Dupont","year":"2004","unstructured":"Dupont M, Gacouin A, Lena H, et al. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest. 2004;125:1815\u201320.","journal-title":"Chest"},{"key":"321_CR63","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<182::AID-PPUL5>3.0.CO;2-T","volume":"29","author":"R Singleton","year":"2000","unstructured":"Singleton R, Morris A, Redding G, et al. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol. 2000;29:182\u20137.","journal-title":"Pediatr Pulmonol"},{"key":"321_CR64","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1111\/j.1445-5994.2011.02444.x","volume":"42","author":"ME Roberts","year":"2012","unstructured":"Roberts ME, Lowndes L, Milne DG, et al. Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis. Intern Med J. 2012;42:e129\u201336.","journal-title":"Intern Med J"},{"key":"321_CR65","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/thorax.55.3.198","volume":"55","author":"H Roberts","year":"2000","unstructured":"Roberts H, Wells A, Milne D, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax. 2000;55:198\u2013204.","journal-title":"Thorax"},{"key":"321_CR66","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/thx.53.8.685","volume":"53","author":"M Gaga","year":"1998","unstructured":"Gaga M, Bentley AM, Humbert M, et al. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax. 1998;53:685\u201391.","journal-title":"Thorax"},{"key":"321_CR67","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMra012519","volume":"346","author":"AF Barker","year":"2002","unstructured":"Barker AF. Bronchiectasis. N Engl J Med. 2002;346:1383\u201393.","journal-title":"N Engl J Med"},{"key":"321_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1034\/j.1399-3003.2000.16a26.x","volume":"16","author":"L Zheng","year":"2000","unstructured":"Zheng L, Tipoe G, Lam W, et al. Endothelin-1 in stable bronchiectasis. Eur Respir J. 2000;16:146\u20139.","journal-title":"Eur Respir J"},{"key":"321_CR69","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1378\/chest.117.2.420","volume":"117","author":"KW Tsang","year":"2000","unstructured":"Tsang KW, Chan K, Ho P, et al. Sputum elastase in steady-state bronchiectasis. Chest. 2000;117:420\u20136.","journal-title":"Chest"},{"key":"321_CR70","first-page":"L413","volume":"264","author":"JB Richman-Eisenstat","year":"1993","unstructured":"Richman-Eisenstat JB, Jorens PG, Hebert CA, et al. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol. 1993;264:L413\u20138.","journal-title":"Am J Physiol"},{"key":"321_CR71","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1164\/ajrccm.162.5.9907064","volume":"162","author":"DK Shum","year":"2000","unstructured":"Shum DK, Chan SC, Ip MS. Neutrophil-mediated degradation of lung proteoglycans: stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis. Am J Resp Crit Care Med. 2000;162:1925\u201331.","journal-title":"Am J Resp Crit Care Med"},{"key":"321_CR72","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1164\/ajrccm\/138.6_Pt_2.S49","volume":"138","author":"R Wilson","year":"1988","unstructured":"Wilson R, Cole PJ. The effect of bacterial products on ciliary function. Am Rev Resp Dis. 1988;138:S49\u201353.","journal-title":"Am Rev Resp Dis"},{"key":"321_CR73","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.trsl.2012.02.005","volume":"160","author":"JM Beck","year":"2012","unstructured":"\u2022 Beck JM, Young VB, Huffnagle GB. The microbiome of the lung. Transl Res. 2012;160:258\u201366. An important review article about a rapidly evolving area of microbiology.","journal-title":"Transl Res"},{"key":"321_CR74","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1164\/rccm.201104-0655OC","volume":"184","author":"ES Charlson","year":"2011","unstructured":"Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Resp Crit Care Med. 2011;184:957\u201363.","journal-title":"Am J Resp Crit Care Med"},{"key":"321_CR75","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jpeds.2010.06.002","volume":"157","author":"KM Hare","year":"2010","unstructured":"Hare KM, Grimwood K, Leach AJ, et al. Respiratory bacterial pathogens in the nasopharynx and lower airways of Australian indigenous children with bronchiectasis. J Pediatr. 2010;157:1001\u20135.","journal-title":"J Pediatr"},{"key":"321_CR76","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/0194599811407279","volume":"145","author":"JM Godoy","year":"2011","unstructured":"Godoy JM, Godoy AN, Ribalta G, et al. Bacterial pattern in chronic sinusitis and cystic fibrosis. Otolaryngol Head Neck Surg. 2011;145:673\u20136.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"321_CR77","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/j.1398-9995.2009.02011.x","volume":"64","author":"JM Guilemany","year":"2009","unstructured":"Guilemany JM, Angrill J, Alobid I, et al. United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient\u2019s quality of life. Allergy. 2009;64:1524\u20139.","journal-title":"Allergy"},{"key":"321_CR78","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0091-6749(05)80126-5","volume":"86","author":"P Bardin","year":"1990","unstructured":"Bardin P, Van Heerden B, Joubert J. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. J Allergy Clin Immunol. 1990;86:82\u20133.","journal-title":"J Allergy Clin Immunol"},{"key":"321_CR79","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaci.2010.03.043","volume":"126","author":"J Brehm","year":"2010","unstructured":"Brehm J, Schuemann B, Fuhlbrigge A, et al. Serum vitamin D levels and severe asthma exacerbations in the childhood asthma management program study. J Allergy Clin Immunol. 2010;126:52\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"321_CR80","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1164\/rccm.201203-0431OC","volume":"186","author":"JM Brehm","year":"2012","unstructured":"Brehm JM, Acosta-Perez E, Klei L, et al. Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. Am J Resp Crit Care Med. 2012;186:140\u20136.","journal-title":"Am J Resp Crit Care Med"},{"key":"321_CR81","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-156-2-201201170-00004","volume":"156","author":"A Lehouck","year":"2012","unstructured":"Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2012;156:105\u201314.","journal-title":"Ann Intern Med"},{"key":"321_CR82","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Bartley J, Camargo CA Jr. Vitamin D and infection. In: Vitamin D: oxidation, immunity & aging. Edited by Gombart A. Taylor & Francis Group, CRC Press; 2012:323\u201348. A recent review of clinical studies investigating the role of vitamin D in infectious disease.","DOI":"10.1201\/b13714-17"},{"key":"321_CR83","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jaci.2010.12.016","volume":"127","author":"P Majak","year":"2011","unstructured":"Majak P, Olszowiec-Chlebna M, Smejda K, et al. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol. 2011;127:1294\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"321_CR84","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(11)61650-4","volume":"379","author":"S Manaseki-Holland","year":"2012","unstructured":"Manaseki-Holland S, Maroof Z, Bruce J, et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet. 2012;379:1419\u201327.","journal-title":"Lancet"},{"key":"321_CR85","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(10)61889-2","volume":"377","author":"AR Martineau","year":"2011","unstructured":"Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011;377:242\u201350.","journal-title":"Lancet"},{"key":"321_CR86","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jama.2012.12505","volume":"308","author":"D Murdoch","year":"2012","unstructured":"\u2022 Murdoch D, Slow S, Chambers S, et al. Effect of vitamin D3 supplementation on upper respiratory infections in healthy adults: A randomised, double blind, placebo-controlled trial. JAMA. 2012;308:1333\u20139. A recent RCT indicating that vitamin D levels above 75nmol\/L may not provide protection against upper respiratory infection.","journal-title":"JAMA"},{"key":"321_CR87","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1017\/S0007114510002333","volume":"104","author":"NO Nielsen","year":"2010","unstructured":"Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case\u2013control study in Greenland. Br J Nutr. 2010;104:1487\u201391.","journal-title":"Br J Nutr"},{"key":"321_CR88","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0140-6736(12)60405-X","volume":"379","author":"AR Martineau","year":"2012","unstructured":"Martineau AR. Bolus-dose vitamin D and prevention of childhood pneumonia. Lancet. 2012;379:1373\u20135.","journal-title":"Lancet"},{"key":"321_CR89","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ajcn\/85.5.1307","volume":"85","author":"A Stephenson","year":"2007","unstructured":"Stephenson A, Brotherwood M, Robert R, et al. Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr. 2007;85:1307\u201311.","journal-title":"Am J Clin Nutr"},{"key":"321_CR90","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4161\/derm.20332","volume":"4","author":"RE Grossmann","year":"2012","unstructured":"Grossmann RE, Zughaier SM, Kumari M, et al. Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial. Dermatoendocrinol. 2012;4:191\u20137.","journal-title":"Dermatoendocrinol"},{"key":"321_CR91","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/ejcn.2012.82","volume":"66","author":"RE Grossmann","year":"2012","unstructured":"Grossmann RE, Zughaier SM, Liu S, et al. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr. 2012;66:1072\u20134.","journal-title":"Eur J Clin Nutr"},{"key":"321_CR92","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3945\/ajcn.110.008490","volume":"93","author":"D Reid","year":"2011","unstructured":"Reid D, Toole B, Knox S, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr. 2011;93:1006\u201311.","journal-title":"Am J Clin Nutr"},{"key":"321_CR93","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","volume":"84","author":"HA Bischoff-Ferrari","year":"2006","unstructured":"Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18\u201328.","journal-title":"Am J Clin Nutr"},{"key":"321_CR94","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1183\/09031936.05.00143404","volume":"26","author":"P Calverley","year":"2005","unstructured":"Calverley P, Pauwels Dagger R, Lofdahl C, et al. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J. 2005;26:406\u201313.","journal-title":"Eur Respir J"},{"key":"321_CR95","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1183\/09031936.00160508","volume":"34","author":"MP Murray","year":"2009","unstructured":"Murray MP, Turnbull K, MacQuarrie S, et al. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Resp J. 2009;34:125\u201331.","journal-title":"Eur Resp J"},{"key":"321_CR96","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11136-004-0624-2","volume":"14","author":"T Eaton","year":"2005","unstructured":"Eaton T, Young P, Fergusson W, et al. The Dartmouth COOP Charts: a simple, reliable, valid and responsive quality of life tool for chronic obstructive pulmonary disease. Qual Life Res. 2005;14:575\u201385.","journal-title":"Qual Life Res"},{"key":"321_CR97","doi-asserted-by":"publisher","first-page":"1s","DOI":"10.1183\/09031936.02.00000102","volume":"37","author":"R Djukanovic","year":"2002","unstructured":"Djukanovic R, Sterk P, Fahy J, et al. Standardised methodology of sputum induction and processing. Eur Resp J. 2002;37:1s\u20132.","journal-title":"Eur Resp J"},{"key":"321_CR98","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1017\/S0950268807008308","volume":"135","author":"JF Aloia","year":"2007","unstructured":"Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect. 2007;135:1095\u20136. author reply 7\u20138.","journal-title":"Epidemiol Infect"},{"key":"321_CR99","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ageing\/afm091","volume":"36","author":"A Avenell","year":"2007","unstructured":"Avenell A, Cook JA, Maclennan GS, et al. Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing. 2007;36:574\u20137.","journal-title":"Age Ageing"},{"key":"321_CR100","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1017\/S0950268809002404","volume":"137","author":"M Li-Ng","year":"2009","unstructured":"Li-Ng M, Aloia JF, Pollack S, et al. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect. 2009;137:1396\u2013404.","journal-title":"Epidemiol Infect"},{"key":"321_CR101","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1086\/654881","volume":"202","author":"I Laaksi","year":"2010","unstructured":"Laaksi I, Ruohola JP, Mattila V, et al. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Inf Dis. 2010;202:809\u201314.","journal-title":"J Inf Dis"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-013-0321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-013-0321-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-013-0321-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-013-0321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T18:49:54Z","timestamp":1745952594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-013-0321-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1007\/s11908-013-0321-9","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}